Skip to main content
FinSpry Logo
FinSpry
RGNX logo
RGNX
(NASDAQ)
REGENXBIO Inc.
$10.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

REGENXBIO (RGNX) Stock Price & Financial Analysis

REGENXBIO Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.68 - $10.32
52-Week High$16.19
52-Week Low$5.46
Open$9.94
Volume1.36M
Average Volume (3M)2.69M
Market Cap537.39M
Shares Outstanding52.43M
Price to Sales (P/S)6.12
Price to Book (P/B)25.49
EV/EBITDA-2.59
Revenue (TTM)87.82M
Net Income (TTM)-290.01M
Free Cash Flow (TTM)-236.40M
EPS (TTM)$-5.59
Profit Margin-330.23%
Operating Margin-292.28%
Return on Equity (ROE)-1375.64%
Debt to Equity3.37
50-Day MA$9.16
200-Day MA$10.61
52-Week Change12.76%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About REGENXBIO

What is the current stock price for RGNX?

As of the latest trading session, RGNX stock trades at $10.25. The 52-week range is $5.46–$16.19, with a day range of $9.68–$10.32.

What is the P/E ratio for RGNX?

The P/E ratio (Price-to-Earnings) for RGNX is shown in the Key Statistics section. This valuation metric helps compare REGENXBIO Inc. to industry peers.

Does RGNX pay dividends?

REGENXBIO does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RGNX?

Based on 9 analysts, the consensus for RGNX is Buy.

What is the market cap of RGNX?

REGENXBIO's market capitalization is $537.4M, classifying it as a small-cap company. REGENXBIO operates in the Healthcare sector within the Biotechnology industry.